Ascendis Pharma A/S (ASND) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 11B |
| Enterprise Value | 11.26B |
| P/E Ratio | 28.22 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 16.55 |
| Price/Book Ratio | 29.19 |
| Enterprise/Revenue | 16.92 |
| Enterprise/EBITDA | 1,186.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.58 |
| Operating Margin | -0.01 |
| Return On Assets | 0.25 |
| Return On Equity | -56.42 |
| Revenue | 691.71M |
| Revenue/Share | 14.06 |
| Gross Profit | 588.53M |
| EBITDA | -109.8M |
| Net Income | -219.03M |
| Diluted EPS | -3.62 |
| Total Cash | 573.42M |
| Total Cash/Share | 9.3 |
| Total Debt | 897.6M |
| Total Debt/Equity | 1.84 |
| Current Ratio | 1 |
| Book Value Per Share | 7.92 |
| 52-Week Change | 52.78 |
| 52-Week High | 271.89 |
| 52-Week Low | 160.86 |
| Moving Average 50 Days | 231.87 |
| Moving Average 200 Days | 218.91 |
| Average Volume | 770,566 |
| Shares Outstanding | 62.11M |
| % Held by Institutions | 89.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |